PHILADELPHIA (PRWEB)
June 17, 2021
InfraScan, a medical device firm specializing in traumatic brain injury diagnostic products, announces today their product development partnership with the United States Department of Defense (DoD) and The Defense Health Agency (DHA) to further expand the Infrascanner device technology.
Working with the DoD/DHA will provide funding to advance InfraScan’s Near-Infrared (NIR) technology used to screen patients for intracranial bleeding and identify those who would most benefit from immediate referral to a higher level of care.
“Teaming up with the DoD/DHA to further the development of the technology and the Infrascanner device was a natural fit for us,” said Baruch Ben-Dor, PhD, president and CEO of InfraScan. “By partnering together, we can effectively decrease product enhancement and development time exponentially while continuing commitment to helping save lives of those who suffer from traumatic brain injuries (TBIs).”
InfraScan has over 1,000 devices deployed in the US and internationally, including with some of the world’s leading neurotrauma and trauma experts. InfraScan also licensed a variety of patents that apply to hemorrhagic and ischemic stroke detection and brain hemorrhage monitoring.
About InfraScan, Inc.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing and distributing portable brain scanners for head injury and stroke assessment based on near infrared (NIR) technologies. The company has received funding from the U.S. Army Medical Materiel Development Activity, U.S. Marine Corps, Office of Naval Research, BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, Ben Franklin Technology Partners of Southeastern Pennsylvania, and from the Philadelphia Industrial Development Corporation. For more information visit http://www.infrascanner.com and follow us @infrascanner.
Contact: Media
David Clarke
Vice President of Business Development
InfraScan, Inc.
(603) 566-5149
Share article on social media or email: